US Stock MarketDetailed Quotes
CYTO Altamira Therapeutics
- 0.5180
- +0.0180+3.60%
Close Nov 4 16:00 ET
1.96MMarket Cap0.03P/E (TTM)
0.5253High0.4800Low35.36KVolume0.5000Open0.5000Pre Close17.89KTurnover0.94%Turnover RatioLossP/E (Static)3.78MShares17.200052wk High0.31P/B1.95MFloat Cap0.450052wk Low--Dividend TTM3.76MShs Float636800.0000Historical High--Div YieldTTM9.06%Amplitude0.4500Historical Low0.5060Avg Price1Lot Size
Altamira Therapeutics Key Stats
EPS
According to the latest financial report of Altamira Therapeutics, the latest earnings per share (TTM) for the company is -960.00. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CHF
Quarterly
Loading...
FCF
Interested in knowing about Altamira Therapeutics's free cash flow? The latest report shows it as -3.80M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: CHF
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Altamira Therapeutics shows that the company's current ratio is 0.43, indicating healthy liquidity.
Currency: CHF
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Altamira Therapeutics, the quick ratio is 0.15, indicating that the company can meet its short-term debt obligations.
Currency: CHF
Quarterly
Loading...
ROE
Want to learn more about the financial health of Altamira Therapeutics? The latest ROE figure is -253.79%, indicating that the company has stable profitability.
Currency: CHF
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Altamira Therapeutics, the total asset return on investment (ROA) is -41.17%.
Currency: CHF
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Altamira Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: CHF
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Altamira Therapeutics, the net profit margin is --, which is a good sign for its profitability.
Currency: CHF
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data